Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Temporal changes in clot lysis and clot stability following tranexamic acid in cardiac surgery

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A rare heterozygous variant in FGB (Fibrinogen Merivale) causing hypofibrinogenemia in a Swedish family

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prediction of bleeding by thromboelastography in ICU patients with haematological malignancy and severe sepsis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Valproic acid modulates platelet and coagulation function ex vivo

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Does whole blood coagulation analysis reflect developmental haemostasis?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Infants with congenital heart defects have reduced brain volumes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Exploring patient experiences in the student outpatient clinic - A contribution to learning

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cardiac Arrhythmias and Impaired Heart Rate Variability in Older Patients With Ventricular Septal Defects

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Mariann Tang
  • Per Wierup
  • Catherine J Rea
  • Jørgen Ingerslev
  • Vibeke E Hjortdal
  • Benny Sørensen
View graph of relations

Cardiac surgery induces a multifactorial coagulopathy. Regular use of tranexamic acid (TXA) is becoming standard of care. Clinical challenges include selecting optimal dosing regimen and balancing the benefit versus risk of additional dosing with antifibrinolytics. The objective was to evaluate the effect of TXA by assessing kinetic properties of plasma clot formation, clot stability, and clot fibrinolysis. The study was a prospective case follow-up of 28 patients undergoing cardiac surgery (mean age 63.9 years, 29% women). Blood samples were analysed at seven time points during the first 48 h after surgery. All patients were treated with TXA, 2 g at start surgery, 1 g during extra corporeal circulation, and 1 g after reversal of heparin. An automated clot lysis assay using tissue factor and tissue plasminogen activator (tPA) was performed to evaluate clot formation, stability, and fibrinolysis. TXA protects against facilitated fibrinolysis and induces up to 13-fold increase in clot stability. All patients showed complete resistance to tPA-induced fibrinolysis during the first 6 h after cardiac surgery declining to 33% of patients at 48 h. Impaired renal function was associated with prolonged resistance to tPA-induced fibrinolysis. Despite inhibition of fibrinolysis with TXA, the overall clot stability declines and the kinetic properties of clot formation were impaired after cardiac surgery. TXA induces a multifold increase in clot resistance to fibrinolysis but does not affect clot formation or clot stability. Monitoring the level of resistance to fibrinolysis may prevent overdosing in particular in patients with impaired renal function.

Original languageEnglish
JournalBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Volume28
Issue number4
Pages (from-to)295-302
Number of pages8
ISSN0957-5235
DOIs
Publication statusPublished - 2017
Externally publishedYes

ID: 65027325